Cellular Stories is a boutique scientific communications company specialising in the translation of complex molecular and cellular science into high-quality visual and interactive educational content for pharmaceutical, biotechnology, and biotech investor audiences. The company’s output is positioned at the intersection of scientific rigour and visual storytelling — offering biopharma companies an alternative to general-purpose medical communications agencies by combining deep molecular biology literacy with design and digital production capability.

The company is entirely output-focused in its online presence, publishing independent demonstration works based on approved drug mechanisms — including T-DM1, daraxonrasib, tisagenlecleucel, and personalised mRNA vaccines — as evidence of its scientific accuracy and production standard. These demonstrations are clearly labelled as independent and unsponsored. The company’s contact model is direct and consultative, with programmes discussed individually via email.

Key Products and Services

Scientific Animation and Visual Content

• Molecular and cellular mechanism animations explaining drug mechanisms of action, target biology, and therapeutic modality function at a level of scientific accuracy appropriate for physician and scientific audiences
• Modality coverage demonstrated includes ADCs (T-DM1), RAS inhibitors (daraxonrasib), CAR-T cell therapies (tisagenlecleucel), and personalised mRNA vaccines

Interactive Digital Experiences

• Interactive websites and digital programmes enabling self-directed exploration of complex scientific content; suitable for HCP engagement, patient education, and conference or partner presentation contexts

Scientific Reports and Literature Reviews

• Written scientific content including literature reviews and scientific reports with publication-quality figures, suitable for medical affairs, clinical, and R&D audiences

Audience-Specific Programme Areas

• Medical Affairs Education — programmes supporting HCP understanding of mechanisms of action, clinical evidence, and differentiated product profile for medical affairs field teams and advisory board engagement
• R&D and Patient Recruitment — scientific content supporting clinical trial recruitment, protocol explanation, and patient understanding of investigational therapies
• Biotech Leadership and Partner Communications — investor-facing and partner-facing scientific communication materials presenting pipeline science, platform mechanisms, and clinical rationale clearly and accurately

Cellular Stories occupies a focused niche in the pharmaceutical scientific communications market as a specialist molecular animation and scientific content studio distinguished by the depth of its scientific literacy relative to general-purpose medical communications agencies. Its independent demonstration portfolio — built around approved, high-complexity drug programmes including CAR-T, ADC, and personalised mRNA vaccine mechanisms — provides a transparent quality benchmark that prospective clients can evaluate directly without requiring a speculative brief. The company’s scope is narrow by design: it does not appear to offer regulatory writing, publication strategy, KOL management, or other conventional medical communications agency services, positioning it instead as a precision content production partner for pharmaceutical and biotech clients whose primary need is scientifically accurate visual and interactive communication of complex biology.